KRAS and cancer: Finally, we provided a detailed view of the somatic mutation landscape of CRCs from biallelic MUTYH pathogenic variant carriers based on a consensus set of 205 cancer genes, identifying specific mutations in KRAS and PIK3CA genes that were associated with CRC tumorigenesis in biallelic MUTYH carriers.